Genomic characteristics and drug screening among organoids derived from non‐small cell lung cancer patients-Reference-Cited by-同舟云学术

Genomic characteristics and drug screening among organoids derived from non‐small cell lung cancer patients

Published:2020-07-07 Issue:8 Volume:11 Page:2279-2290
ISSN:1759-7706
Container-title:Thoracic Cancer
language:en
Short-container-title:Thorac Cancer

Author:

Chen Jing‐Hua¹²³,Chu Xiang‐Peng²,Zhang Jia‐Tao¹²,Nie Qiang²,Tang Wen‐Fang²⁴,Su Jian²,Yan Hong‐Hong²,Zheng Hong‐Ping⁵,Chen Ze‐Xin⁵,Chen Xin⁵,Song Meng‐Meng⁶,Yi Xin⁶,Li Pan‐Song⁶,Guan Yan‐Fang⁶,Li Gang¹,Deng Chu‐Xia⁷,Rosell Rafael⁸,Wu Yi‐Long²,Zhong Wen‐Zhao¹²^ORCID

Affiliation:

1. The Second School of Clinical MedicineSouthern Medical University Guangzhou China

2. Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital, Guangdong Key Laboratory of Lung Cancer Translational MedicineSouth China University of Technology & Guangdong Academy of Medical Sciences Guangzhou China

3. Guangzhou Twelfth People's Hospital Guangzhou China

4. Shantou University Medical College Shantou China

5. Accurate International Biotechnology Co. Guangzhou China

6. Geneplus‐Beijing Institute Beijing China

7. University of Macau. Cancer Centre, Faculty of Health SciencesUniversity of Macau Macau China

8. Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol Campus Can Ruti (Edifici Muntanya)Ctra. de Can Ruti Barcelona Spain

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1759-7714.13542

Reference44 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2. Deconstructing the third dimension – how 3D culture microenvironments alter cellular cues

3. Three‐dimensional cell culture: A powerful tool in tumor research and drug discovery;Lv D;Oncol Lett,2017

4. Phase II and phase III failures: 2013–2015

5. Concise Review: Current Status of Three-Dimensional Organoids as Preclinical Models

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent advances in lung cancer organoid (tumoroid) research (Review);Experimental and Therapeutic Medicine;2024-08-01

2. Efficacy Evaluation of Adjuvant Therapeutic Drugs Against Early and Middle Stage Non‐Small Cell Lung Cancer Organoids;Advanced Therapeutics;2024-07-18

3. Organoid Intelligence: Bridging Artificial Intelligence for Biological Computing and Neurological Insights;Biochemistry;2024-06-26

4. Nanoplasmonic Single‐Tumoroid Microarray for Real‐Time Secretion Analysis;Advanced Science;2024-06-24

5. Co-occurring EGFR p.E709X Mutation Mediates Primary Resistance to the Third-Generation EGFR-TKIs in EGFR p.G719X-Mutant Patients with Advanced NSCLC;Clinical Cancer Research;2024-04-05